The Bioinformatics CRO Podcast
Episode 22 with Brett Abrahams
Brett Abrahams, Executive VP of R&D at Magnolia Neurosciences, discusses his work on chemotherapy-induced peripheral neuropathy and other brain disorders.
On The Bioinformatics CRO Podcast, we sit down with scientists to discuss interesting topics across biomedical research and to explore what made them who they are today.
You can listen onSpotify, Apple Podcasts, Google Podcasts, Amazon, and Pandora.
Brett is the Vice-President of Research & Development at Magnolia Neurosciences, which is developing therapies for chemotherapy-induced peripheral neuropathy and other neurological disorders. Previously he was head of pre-clinical biology at Ovid Therapeutics.
Transcript of Episode 22: Brett Abrahams